Navigation Links
Regulators Object Drug Produced from Genetically Engineered Farm Animals

European regulators have not given the green signal to a drug produced in the milk of genetically engineered farm animals// . This is a step retrograde to a budding industry that sought to enable low cost pharmaceutical options from farm animals

GTC Biotherapeutics, proponents of this drug, have decided to appeal the decision, expressing their opinion that the verdict came about only on the basis of a problem in the clinical trial, and certainly not from the fact that the drug was produced in the goats.

With a new technology there is a conservatism that is not inappropriate, Geoffrey Cox, chief executive of GTC, said during a conference call with analysts. But he added, There is no way with this company and what we have achieved over 15 years that we will let this block us from getting the product to market.

Companies like the GTC inject human genes into the animals that cause them to produce a human protein in their milk. The animal’s milk can then be used to extract the protein which can later be purified and used as a drug.

This method is cost effective and less cumbersome to produce such types of biotechnology drugs. Cancer-fighting monoclonal antibodies and many such drugs are produced using cultures of genetically engineered animal cells. These factories are a very expensive proposition costing several hundred million dollars for each factory.

Many other protein drugs, similar to the one developed by GTC, are done after the protein is extracted from donated blood. But these quantities in donated blood are found in very minimal quantities and run short to meet the actual demand. According to GTC, almost 90,000 blood donations would be required to produce the amount of protein the goats can produce in just one year.

Drug companies have been reticent to try this technology, mainly because of the wariness portrayed by drug regulators. GTC now proposes to seek the approval on its own steam to take its efforts in biotechnology forward.
'"/>




Related medicine news :

1. A brush with the U.S. Regulators can cost a fortune
2. Cancer-causing Property Of Teflon Leaves US Regulators Concerned
3. Australian Drug Regulators Call for Revamp On The Pharmaceutical Surveillance
4. Drug Regulators Need To Think In Long-Term, Say Charities
5. European Regulators Investigate Common Painkiller Drugs
6. Canadian Regulators allow Silicone Breast Implants in Market
7. New Study Challenges How Regulators Determine Risk
8. Researchers Urge Regulators to Rethink Strategies for Soot Emission
9. Local Community Objects to Mental Facility
10. Doctors Object To Elective Surgery Cuts In New South Wales
11. Healthy People 2010 Objectives Aims To Reduce Oral Health Disparities In Society
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/21/2017)... ... , ... Chicago plastic surgeon, Dr. Anil R. Shah, MD , has ... bony lump located on the forehead usually attributed to a facial fracture. Their appearance ... Dr. Shah has discovered an approach that is minimally invasive. He is an expert ...
(Date:4/21/2017)... (PRWEB) , ... April 21, 2017 , ... Dudnyk has ... identity emphasizes the agency’s conviction that the full potential of specialty and orphan brands ... equally appreciated and aligned. , “The Unifying Effect is at the heart of ...
(Date:4/21/2017)... ... April 21, 2017 , ... The Hong Kong Polytechnic ... 3D printing facility among higher education institutions in Hong Kong to support teaching, learning ... of the range and quantity of facilities in Hong Kong. , With an ...
(Date:4/21/2017)... ... April 21, 2017 , ... Airway ... new partnership with the highly regarded and well renowned Asian distributor, Discovery Sleep. ... & myTAP PAP Nasal Pillow Mask, and will stabilize and strengthen Airway’s presence ...
(Date:4/21/2017)... , ... April 21, 2017 , ... Providing for loved ... the estate planning process, or where to even begin. “Now more than ever there ... are to properly protect yourself and your family,” said attorney Lisa Edgar Dickman, founder ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)...  Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), ... it will be participating in the Deutsche Bank Securities ... in Boston, Massachusetts on Wednesday, ... a.m. Eastern Time. A live webcast of ... Relations website at http://investor.zimmerbiomet.com .  The webcast will ...
(Date:4/20/2017)... 2017  CVS Pharmacy, the retail division of ... store design to enhance the retail customer experience ... products and expanded beauty selections paired with informational ... new offerings. Together with its innovative digital programs, ... customer experience at CVS Pharmacy.  ...
(Date:4/20/2017)... -- Eyevensys, a private biotechnology company developing ... technology that enables the safe, local, sustained production of ... range of ophthalmic diseases, announces it has received approval ... (MHRA) to advance its technology into clinical development. ... The EyeCET platform ...
Breaking Medicine Technology: